logo
Plus   Neg
Share
Email
Comment

FDA Posts Briefing Documents For Advisory Committee Meeting Reviewing Gattex

NPS Pharmaceuticals, Inc. (NPSP) announced that the U.S. Food and Drug Administration, or FDA, has posted briefing materials for the October 16, 2012 Gastrointestinal Drugs Advisory Committee meeting to review Gattex (teduglutide).

Gattex is a new, recombinant analog of human glucagon-like peptide 2 (a protein involved in the rehabilitation of the intestinal lining) being developed for the treatment of adults with short bowel syndrome.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Lucky Charms' new marshmallow - the magical unicorn is ready to attract kids and cereal lovers. This is the first marshmallow to be introduced in the last ten years. Walmart Inc. (WMT) reported fourth-quarter adjusted profit per share of $1.33 compared to $1.30, prior year. On average, 29 analysts polled by Thomson Reuters expected the company to report profit per share of $1.37 for the quarter. Analysts' estimates typically exclude special items. The company said... Shares of BHP Billiton plc were losing around 4 percent in the morning trading in London after the Anglo-Australian mining giant reported Tuesday sharply lower profit in its first half on US tax charge, despite higher revenues. Further, the company announced higher dividend, but trimmed its forecast for Group copper equivalent volume growth for fiscal 2018.
comments powered by Disqus
Follow RTT